IL101241A
(en)
*
|
1992-03-16 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
|
DE4244122C1
(de)
*
|
1992-12-24 |
1994-06-01 |
Sanol Arznei Schwarz Gmbh |
Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
|
ATE223231T1
(de)
*
|
1993-04-19 |
2002-09-15 |
Inst Advanced Skin Res Inc |
Mikroemulsionszubereitung enthaltend eine schwer absorbierbare substanz
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5576016A
(en)
*
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
IL106578A
(en)
*
|
1993-08-03 |
2000-08-13 |
Yissum Res Dev Co |
Pharmaceutical compositions for drug targeting
|
FR2709666B1
(fr)
*
|
1993-09-07 |
1995-10-13 |
Oreal |
Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
US5672358A
(en)
*
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
JPH0827018A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sanwa Kagaku Kenkyusho Co Ltd |
生理活性ペプチド又は蛋白質を含有する薬剤組成物
|
CA2232410C
(en)
*
|
1995-09-18 |
2003-06-17 |
United States Army Medical Research Materiel Command (Usamrmc) |
Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
|
JPH11513698A
(ja)
*
|
1995-10-25 |
1999-11-24 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
神経保護物質およびパーフルオロケミカルの注射剤
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
ES2118033B1
(es)
*
|
1996-02-16 |
1999-07-01 |
Bial Ind Farmaceutica S A |
Formulacion farmaceutica antiinflamatoria.
|
SE9602280D0
(sv)
*
|
1996-06-10 |
1996-06-10 |
Pharmatrix Ab |
Immunstimulerande lipidformulering
|
AU727447B2
(en)
*
|
1996-07-03 |
2000-12-14 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
WO1998007414A1
(en)
*
|
1996-08-22 |
1998-02-26 |
Research Triangle Pharmaceuticals Ltd. |
Compositions comprising microparticles of water-insoluble substances and method for preparing same
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
SE9603667D0
(sv)
*
|
1996-10-08 |
1996-10-08 |
Astra Ab |
Pharmaceutical compositions
|
US6071904A
(en)
*
|
1996-12-11 |
2000-06-06 |
Alcon Laboratories, Inc. |
Process for manufacturing ophthalmic suspensions
|
US7060277B2
(en)
*
|
1996-12-30 |
2006-06-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins
|
US6537561B1
(en)
*
|
1997-02-27 |
2003-03-25 |
Nippon Shinyaku Co., Ltd. |
Fat emulsion for oral administration
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US5980912A
(en)
*
|
1997-03-25 |
1999-11-09 |
Zonagen, Inc. |
Chitosan induced immunopotentiation
|
SE9702776D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Pharmacia & Upjohn Ab |
Method of preparing pharmaceutical compositions
|
US6306433B1
(en)
|
1997-08-12 |
2001-10-23 |
Pharmacia Ab |
Method of preparing pharmaceutical compositions
|
IL122084A
(en)
*
|
1997-10-31 |
1999-09-22 |
Lurident Ltd |
Formulation for personal care with mucoadhesive properties
|
US6270464B1
(en)
|
1998-06-22 |
2001-08-07 |
Artemis Medical, Inc. |
Biopsy localization method and device
|
GB9726916D0
(en)
*
|
1997-12-19 |
1998-02-18 |
Danbiosyst Uk |
Nasal formulation
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US6017545A
(en)
*
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
WO1999046242A1
(fr)
|
1998-03-09 |
1999-09-16 |
Takeda Chemical Industries, Ltd. |
Derives de cycloalcene, leur procede de fabrication et d'utilisation
|
DE19819273A1
(de)
*
|
1998-04-30 |
1999-11-11 |
Pharmatec International S Giul |
Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
|
BR9910269A
(pt)
*
|
1998-05-07 |
2001-01-09 |
Corixa Corp |
Composição adjuvante e métodos para seu uso
|
TWI241915B
(en)
|
1998-05-11 |
2005-10-21 |
Ciba Sc Holding Ag |
A method of preparing a pharmaceutical end formulation using a nanodispersion
|
DE69914742T2
(de)
|
1998-05-29 |
2004-11-25 |
Skyepharma Canada Inc., Verdun |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
CA2337794A1
(en)
*
|
1998-07-02 |
2000-01-13 |
Jennifer D. Tousignant |
Transgene expression in polarized cells
|
DE19830375A1
(de)
*
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
JP2007262088A
(ja)
*
|
1998-08-31 |
2007-10-11 |
Nipro Corp |
栄養輸液製剤
|
DE69929128T2
(de)
*
|
1998-08-31 |
2006-06-29 |
Nipro Corp. |
Nährstoffinfusionspräparat
|
AU6333499A
(en)
*
|
1998-10-14 |
2000-05-01 |
Cognis Deutschland Gmbh |
Use of nanoscale sterols and sterol esters
|
ID29270A
(id)
|
1998-11-20 |
2001-08-16 |
Rtp Pharma Inc |
Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
|
FR2787326B1
(fr)
*
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
JP2002534370A
(ja)
*
|
1998-12-30 |
2002-10-15 |
デクセル リミテッド |
サイクロスポリンを送達するための分散可能な濃縮物
|
US7655252B2
(en)
*
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US7767216B2
(en)
*
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
US8232320B2
(en)
*
|
1999-04-28 |
2012-07-31 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
WO2000067728A2
(de)
*
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
|
CA2375371A1
(en)
*
|
1999-06-04 |
2000-12-14 |
Skyepharma Inc. |
Oil-core compositions for the sustained release of hydrophobic drugs
|
US7919113B2
(en)
*
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US6541025B1
(en)
|
1999-12-30 |
2003-04-01 |
Shear/Kershman Laboratories, Inc. |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
US6514523B1
(en)
|
2000-02-14 |
2003-02-04 |
Ottawa Heart Institute Research Corporation |
Carrier particles for drug delivery and process for preparation
|
ATE331530T1
(de)
|
2000-02-15 |
2006-07-15 |
Id Biomedical Corp Quebec |
Proteasom-influenzavirus-impfstoffzusammensetzu g
|
FR2805761B1
(fr)
*
|
2000-03-02 |
2002-08-30 |
Mainelab |
Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
|
AU2001245552A1
(en)
*
|
2000-03-09 |
2001-09-17 |
Emory University |
Transcutaneous immunization for large particulate antigens
|
US6861060B1
(en)
|
2000-04-21 |
2005-03-01 |
Elena Luriya |
Personal care formulations
|
DE10027948A1
(de)
*
|
2000-06-08 |
2001-12-20 |
Henkel Kgaa |
Verfahren zur Herstellung von Nanopartikel-Suspensionen
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
EP2545937A1
(de)
*
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsionsimpfstoffe
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
CN102294023A
(zh)
*
|
2001-07-26 |
2011-12-28 |
奥塔戈创新公司 |
抗原组合物
|
EP1420783A4
(de)
*
|
2001-08-03 |
2009-09-30 |
Takeda Pharmaceutical |
Stabile emulsionszusammensetzung
|
US7125568B2
(en)
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL145926A0
(en)
*
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
JP4549625B2
(ja)
*
|
2002-01-05 |
2010-09-22 |
株式會社アモーレパシフィック |
人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US6899890B2
(en)
*
|
2002-03-20 |
2005-05-31 |
Kv Pharmaceutical Company |
Bioadhesive drug delivery system
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
US8435942B2
(en)
*
|
2002-05-31 |
2013-05-07 |
Transdermal Biotechnology, Inc. |
Methods for formulating stabilized insulin compositions
|
US20040018237A1
(en)
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
HUP0202032A2
(hu)
*
|
2002-06-19 |
2004-10-28 |
D. Endre Radics |
Nanoemulziós formulációban található bioaktív anyagok emberi szervezetbe való bevitele a szájüreg nyálkahártyáján keresztül, mechanikus pumpájú spray által.
|
AU2003257285A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Micrologix Biotech Inc. |
Inhibitors of rna dependent rna polymerase and uses thereof
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
CA2503490C
(en)
*
|
2002-10-21 |
2012-04-03 |
Allvivo, Inc. |
Medical device surface coating comprising bioactive compound
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
MXPA05004278A
(es)
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Espuma cosmetica y farmaceutica.
|
ITMI20022323A1
(it)
*
|
2002-10-31 |
2004-05-01 |
Maria Rosa Gasco |
Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
|
US7255867B2
(en)
*
|
2002-11-15 |
2007-08-14 |
Id Biomedical Corporation Of Quebec |
Vaccine
|
WO2004073684A2
(en)
|
2003-02-14 |
2004-09-02 |
Children's Hospital & Research Center At Oakland |
Lipophilic drug delivery vehicle and methods of use thereof
|
WO2004084859A2
(en)
|
2003-03-21 |
2004-10-07 |
Nastech Pharmaceutical Company Inc. |
Nasal calcitonin formulations containing chlorobutanol
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
US7368537B2
(en)
*
|
2003-07-15 |
2008-05-06 |
Id Biomedical Corporation Of Quebec |
Subunit vaccine against respiratory syncytial virus infection
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
EP1667713A1
(de)
*
|
2003-09-15 |
2006-06-14 |
ID Biomedical Corporation of Quebec |
Masern-untereinheit-vakzine
|
WO2005030172A1
(en)
*
|
2003-09-24 |
2005-04-07 |
The Regents Of The University And Methods |
Antimicrobial nanoemulsion compositions and methods
|
WO2005041933A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Teva Pharmaceutical Industries, Ltd. |
Nanoparticles for drug delivery
|
EP1711163A2
(de)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
|
US20080019926A1
(en)
*
|
2004-04-19 |
2008-01-24 |
Marie-Pierre Krafft |
Lung Surfactant Supplements
|
ITMI20041151A1
(it)
*
|
2004-06-09 |
2004-09-09 |
Maria Rosa Gasco |
Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
|
US7348802B2
(en)
*
|
2004-06-15 |
2008-03-25 |
Stmicroelectronics Pvt. Ltd. |
Differential receiver
|
RU2387453C2
(ru)
*
|
2004-06-25 |
2010-04-27 |
АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН ОФ КВЕБЕК |
Композиции и способы лечения неврологических нарушений
|
US20060286124A1
(en)
*
|
2004-06-30 |
2006-12-21 |
Id Biomedical Corporation Of Quebec |
Vaccine compositions and methods of treating coronavirus infection
|
US7871632B2
(en)
*
|
2004-07-12 |
2011-01-18 |
Adventrx Pharmaceuticals, Inc. |
Compositions for delivering highly water soluble drugs
|
US20060057216A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Salamone Joseph C |
Low-obscuration image transmitting particulate ocular therapeutic formulations
|
EP1674085A1
(de)
*
|
2004-12-22 |
2006-06-28 |
Universite Libre De Bruxelles |
Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
|
CA2600054A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Combe Incorporated |
Stable mixed emulsions
|
FR2885538B1
(fr)
*
|
2005-05-16 |
2007-08-10 |
Univ Claude Bernard Lyon |
Nouveau procede de preparation de particules lipidiques solides, mettant en oeuvre un reacteur membranaire
|
FR2887457B1
(fr)
*
|
2005-06-23 |
2007-10-05 |
Fond Bettencourt Schueller |
Vaccination par ciblage transcutane
|
WO2008010788A2
(en)
|
2005-07-18 |
2008-01-24 |
University Of Massachusetts Lowell |
Compositions and methods for making and using nanoemulsions
|
EP1926466A2
(de)
*
|
2005-09-19 |
2008-06-04 |
Combe Incorporated |
Stabile emulsionssysteme mit hoher salzverträglichkeit
|
PL1933809T3
(pl)
*
|
2005-10-11 |
2012-09-28 |
Yissum Research Development Company Of The Hebrew Univ Of Jerusalem |
Kompozycje do dostarczania donosowego
|
US7638142B2
(en)
*
|
2005-10-12 |
2009-12-29 |
Vitamin Science, Inc. |
Therapeutic composition for the treatment of dry eye syndrome
|
WO2007054339A1
(de)
*
|
2005-11-10 |
2007-05-18 |
Vortex-Nanofluid Gmbh |
Langzeitstabile dispersion und verfahren zur herstellung der dispersion
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
EP3144013B1
(de)
|
2005-12-01 |
2018-11-14 |
University Of Massachusetts Lowell |
Botulin-nanoemulsionen
|
KR100792557B1
(ko)
*
|
2006-04-05 |
2008-01-09 |
한남대학교 산학협력단 |
나노 캡슐화를 이용하여 제조된 지질 핵 및 고분자 쉘구조를 갖는 단백질 약물 전달용 나노 미립구
|
US9839685B2
(en)
*
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
US20080038295A1
(en)
*
|
2006-04-13 |
2008-02-14 |
Regents Of The University Of Michigan |
Compositions and methods for orthopox virus vaccination
|
US20070243137A1
(en)
*
|
2006-04-18 |
2007-10-18 |
Nanoprobes, Inc. |
Cell and sub-cell methods for imaging and therapy
|
US20100034888A1
(en)
*
|
2006-09-15 |
2010-02-11 |
Hubert Clemens Pellikaan |
Granulate containing a pharmaceutically active substance and method for its manufacture
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
CN101848702B
(zh)
|
2006-12-01 |
2013-07-17 |
安特里奥公司 |
两亲实体纳米粒子
|
JP5292304B2
(ja)
|
2006-12-01 |
2013-09-18 |
アンテリオス, インコーポレイテッド |
ペプチドナノ粒子およびその使用
|
AU2008213356A1
(en)
*
|
2007-02-07 |
2008-08-14 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Recombinant antigens of human cytomegalovirus (HCMV)
|
JP5249248B2
(ja)
*
|
2007-03-05 |
2013-07-31 |
ワシントン ユニバーシティー |
膜組み込みペプチドのためのナノ粒子輸送システム
|
US11246831B2
(en)
|
2007-03-30 |
2022-02-15 |
Particle Sciences, Inc. |
Particle formulations and uses thereof
|
WO2008137747A1
(en)
|
2007-05-02 |
2008-11-13 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
WO2008135828A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
WO2008151022A2
(en)
|
2007-05-31 |
2008-12-11 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
US8974827B2
(en)
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
EP2200613B1
(de)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazin-derivate und ihre verwendungen
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
US8906855B2
(en)
|
2007-12-22 |
2014-12-09 |
Vivacelle Bio, Inc. |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8618056B2
(en)
|
2007-12-22 |
2013-12-31 |
Cuthbert O. Simpkins |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8063020B2
(en)
|
2007-12-22 |
2011-11-22 |
Simpkins Cuthbert O |
Resuscitation fluid
|
EP2242476A2
(de)
|
2008-01-14 |
2010-10-27 |
Foamix Ltd. |
Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
|
US8609733B2
(en)
*
|
2008-05-19 |
2013-12-17 |
Massachusetts Institute Of Technology |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
US8658699B2
(en)
*
|
2008-05-19 |
2014-02-25 |
Massachusetts Institute Of Technology |
Chemical permeation enhancers enhance nerve blockade by toxins
|
CA2725329C
(en)
*
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
WO2009158678A1
(en)
|
2008-06-27 |
2009-12-30 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use therefor
|
DE102008045152A1
(de)
*
|
2008-07-09 |
2010-01-14 |
Universität Duisburg-Essen |
Künstliche Sauerstoffträger und ihre Verwendung
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
WO2010036945A2
(en)
|
2008-09-26 |
2010-04-01 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2010042499A1
(en)
*
|
2008-10-06 |
2010-04-15 |
Banner Pharmacaps, Inc. |
Stable solutions of orlistat for pharmaceutical dosage forms
|
WO2010057197A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
FR2939699B1
(fr)
|
2008-12-12 |
2011-05-06 |
Univ Angers |
Procede de preparation de nanoparticules lipidiques
|
CN102300555B
(zh)
*
|
2009-01-30 |
2015-06-17 |
卡斯伯特·O·辛普金斯 |
复苏液
|
US8957207B2
(en)
|
2009-03-24 |
2015-02-17 |
Proteus S.A. |
Methods for producing phycotoxins
|
CA2756685C
(en)
*
|
2009-04-15 |
2019-12-24 |
Oxygen Biotherapeutics, Inc. |
Emulsions of perfluorocarbons
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
WO2010132833A1
(en)
*
|
2009-05-14 |
2010-11-18 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
CN101579291B
(zh)
*
|
2009-05-20 |
2011-06-15 |
清华大学 |
一种白藜芦醇磷脂复合物纳米乳液及其制备方法与应用
|
WO2010148111A1
(en)
*
|
2009-06-16 |
2010-12-23 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
AU2010279384A1
(en)
|
2009-08-05 |
2012-03-01 |
Wake Forest University |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
MX359879B
(es)
|
2009-10-02 |
2018-10-12 |
Foamix Pharmaceuticals Ltd |
Composiciones tópicas de tetraciclina.
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
WO2011075623A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Latitude Pharmaceuticals, Inc. |
One - phase gel compos ition compri s ing phos pholi pids
|
FR2956320B1
(fr)
*
|
2010-02-17 |
2013-12-20 |
Commissariat Energie Atomique |
Nanoemulsion pour la delivrance d'au moins deux agents d'interet
|
US20110229516A1
(en)
*
|
2010-03-18 |
2011-09-22 |
The Clorox Company |
Adjuvant phase inversion concentrated nanoemulsion compositions
|
ES2548681T3
(es)
|
2010-03-24 |
2015-10-20 |
Medesis Pharma |
Sistema micelar inverso que comprende iones metálicos y uso del mismo
|
CA2793959C
(en)
|
2010-03-25 |
2019-06-04 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
TWI540319B
(zh)
|
2010-03-29 |
2016-07-01 |
中央研究院 |
以細胞質譜分析定量細胞所攝入之奈米/微米粒子
|
CN102232932B
(zh)
*
|
2010-04-27 |
2013-06-05 |
重庆莱美药业股份有限公司 |
果胶-阿霉素轭合物的冻干制剂及制备方法
|
US10758630B2
(en)
|
2010-08-13 |
2020-09-01 |
The Johns Hopkins University |
Topical compositions and methods of detection and treatment
|
US8658676B2
(en)
*
|
2010-10-12 |
2014-02-25 |
The Medicines Company |
Clevidipine emulsion formulations containing antimicrobial agents
|
WO2012094541A2
(en)
*
|
2011-01-05 |
2012-07-12 |
The Regents Of The University Of California |
Acoustically responsive particles with decreased cavitation threshold
|
JP2014508166A
(ja)
|
2011-03-17 |
2014-04-03 |
トランスダーマル バイオテクノロジ インコーポレーテッド |
局所的一酸化窒素システム及びその使用方法
|
SI2691530T1
(en)
|
2011-06-10 |
2018-08-31 |
Oregon Health & Science University |
CMV glycoproteins and recombinant vectors
|
EA032840B8
(ru)
|
2011-06-22 |
2020-06-18 |
Вайоми Терапеутикс Лимитед |
Пролекарства на основе конъюгатов противогрибковых агентов и их применение
|
US20130189754A1
(en)
|
2011-09-12 |
2013-07-25 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
JP2014526519A
(ja)
*
|
2011-09-16 |
2014-10-06 |
ナノケア テクノロジーズ,インコーポレイティド |
ジャスモネート化合物の組成物および使用方法
|
KR101803902B1
(ko)
*
|
2011-09-16 |
2017-12-04 |
(주)아모레퍼시픽 |
세라마이드를 포함하는 피부 외용제 조성물
|
EP2586461A1
(de)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Von einem eingehüllten Virus abgeleitete Virenpartikel
|
US20130142878A1
(en)
*
|
2011-12-01 |
2013-06-06 |
Flow Pharma, Inc. |
Peptide particle formulation
|
EP4218808A3
(de)
|
2012-03-12 |
2023-08-09 |
Advanced BioAdjuvants, LLC |
Adjuvans- und impfstoffzusammensetzungen
|
TWI483747B
(zh)
*
|
2012-05-29 |
2015-05-11 |
Univ Nat Chiao Tung |
口服式藥物載體及其製備方法
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US20140234433A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Nicholas V. Perricone |
Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin
|
US20160000905A1
(en)
|
2013-02-25 |
2016-01-07 |
Particle Sciences, Inc. |
Nanoparticle Delivery of TLR Agonists and Antigens
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
KR20210062693A
(ko)
|
2013-03-15 |
2021-05-31 |
더 칠드런스 메디칼 센터 코포레이션 |
지속성 국소 마취용 네오삭시톡신 조합 제형
|
FR3008900B1
(fr)
*
|
2013-07-25 |
2018-03-30 |
Centre Nat Rech Scient |
Nanoparticules lipidiques multicompartimentees
|
EP2848937A1
(de)
|
2013-09-05 |
2015-03-18 |
International Aids Vaccine Initiative |
Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
|
US10058604B2
(en)
|
2013-10-07 |
2018-08-28 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
US9925149B2
(en)
|
2013-10-14 |
2018-03-27 |
Nanosphere Health Sciences, Llc |
Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
|
JP6491203B2
(ja)
|
2013-10-25 |
2019-03-27 |
インスメッド インコーポレイテッド |
プロスタサイクリン化合物、組成物およびその使用方法
|
EA201691348A1
(ru)
*
|
2013-12-31 |
2016-11-30 |
Инфекшес Дизиз Рисерч Инститьют |
Однофлаконные вакцинные составы
|
US9895311B2
(en)
*
|
2014-09-25 |
2018-02-20 |
Pharmiva Ab |
Foam-forming compositions and methods for delivering an active to a body cavity
|
US10343979B2
(en)
|
2014-11-18 |
2019-07-09 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
US20160151285A1
(en)
*
|
2014-11-28 |
2016-06-02 |
University Of Malaya |
Method to produce slow release delivery carrier lipid nanoparticles of different log p value
|
CA3050535C
(en)
|
2014-12-15 |
2021-11-09 |
Richard Clark Kaufman |
Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of anti-inflammatory nutraceuticals
|
MX2017008655A
(es)
|
2014-12-31 |
2018-04-10 |
Nanocare Tech Inc |
Derivados de jasmonato y composiciones de los mismos.
|
WO2017054071A1
(en)
*
|
2015-01-21 |
2017-04-06 |
Willinsky Michael |
Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
|
EP3268043A4
(de)
*
|
2015-03-10 |
2018-12-19 |
Nanosphere Health Sciences, LLC |
Lipidnanoteilchenzusammensetzungen und verfahren als träger von cannabinoiden in standardisierten präzisionsabgemessenen darreichungsformen
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
EP3072901A1
(de)
|
2015-03-23 |
2016-09-28 |
International Aids Vaccine Initiative |
Lösliche hiv-1-hüllglykoproteintrimere
|
US20160346221A1
(en)
|
2015-06-01 |
2016-12-01 |
Autotelic Llc |
Phospholipid-coated therapeutic agent nanoparticles and related methods
|
KR20180082457A
(ko)
*
|
2015-10-16 |
2018-07-18 |
마리누스 파마슈티컬스 인코포레이티드 |
나노입자들을 포함하는 주사용 뉴로스테로이드 제제들
|
CA3027368A1
(en)
|
2016-06-13 |
2017-12-21 |
Ascendia Pharmaceuticals, Llc |
Parenteral sustained-release delivery of carvedilol disperse systems
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
CN110198703A
(zh)
|
2016-11-21 |
2019-09-03 |
艾里奥治疗公司 |
大试剂的透皮递送
|
WO2018152334A1
(en)
*
|
2017-02-15 |
2018-08-23 |
Molecular Infusions, Llc |
Formulations
|
PT3628002T
(pt)
|
2017-05-23 |
2023-05-10 |
Pharmiva Ab |
Composições de formação de espuma para entregar um activo a uma cavidade corporal
|
TWI719263B
(zh)
*
|
2017-10-27 |
2021-02-21 |
財團法人國家衛生研究院 |
用於鼻黏膜之奈米級乳液免疫載劑及其製備方法
|
KR102052912B1
(ko)
*
|
2018-03-30 |
2019-12-06 |
중앙대학교 산학협력단 |
산소를 함유하는 나노 버블의 제조 방법, 나노 버블 및 이를 포함하는 약물 전달체
|
WO2020016659A2
(en)
*
|
2018-07-18 |
2020-01-23 |
Glatt Gmbh |
Multiparticulate formulations of cannabinoids
|
SG11202106144VA
(en)
*
|
2018-12-11 |
2021-07-29 |
Disruption Labs Inc |
Compositions for the delivery of therapeutic agents and methods of use and making thereof
|
WO2020186246A1
(en)
*
|
2019-03-13 |
2020-09-17 |
Ulagaraj Selvaraj |
Stabilized solid nanoparticle formulations of cannabinoids and cannabinoid analogs with reduced ostwald ripening for oral, inhalation, nasal and parenteral drug delivery
|
TR201905678A2
(tr)
*
|
2019-04-16 |
2020-11-23 |
Istanbul Medipol Ueniversitesi |
Kurkumi̇n ve pi̇peri̇n doğal bi̇leşenleri̇ni̇ i̇hti̇va eden kati li̇pi̇t emulsi̇yonlarinin tedavi̇ amaçli uygulamalari
|
JP7455144B2
(ja)
|
2019-04-29 |
2024-03-25 |
インスメッド インコーポレイテッド |
トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法
|
US20200352191A1
(en)
*
|
2019-05-06 |
2020-11-12 |
Karl Lonsbery |
Edible formulations and uses thereof
|
CA3166631A1
(en)
*
|
2020-01-02 |
2021-07-08 |
Spoke Sciences, Inc. |
Systems and methods for generating homogenous mixtures of brewed beverages and active ingredients
|
US20220031625A1
(en)
*
|
2020-07-31 |
2022-02-03 |
Altaire Pharmaceuticals, Inc. |
Ophthalmic compositions for delivering meibum-like materials
|
US11058637B1
(en)
*
|
2020-11-25 |
2021-07-13 |
King Abdulaziz University |
Surface-modified emulsomes for intranasal delivery of drugs
|
WO2023108513A1
(zh)
*
|
2021-12-16 |
2023-06-22 |
威海天原生物科技有限公司 |
植物油制剂及其制备方法
|